The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 27, 2014

Filed:

Jan. 14, 2009
Applicants:

Todd M. Heidelbaugh, Fountain Valley, CA (US);

Ken Chow, Newport Coast, CA (US);

Santosh C. Sinha, Ladera Ranch, CA (US);

Phong X. Nguyen, Placentia, CA (US);

Wenkui K. Fang, Irvine, CA (US);

Ling LI, Irvine, CA (US);

Janet A. Takeuchi, Anaheim, CA (US);

Smita S. Bhat, Irvine, CA (US);

Inventors:

Todd M. Heidelbaugh, Fountain Valley, CA (US);

Ken Chow, Newport Coast, CA (US);

Santosh C. Sinha, Ladera Ranch, CA (US);

Phong X. Nguyen, Placentia, CA (US);

Wenkui K. Fang, Irvine, CA (US);

Ling Li, Irvine, CA (US);

Janet A. Takeuchi, Anaheim, CA (US);

Smita S. Bhat, Irvine, CA (US);

Assignee:

Allergan, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/422 (2006.01); A61K 31/497 (2006.01); C07D 241/12 (2006.01); C07D 263/12 (2006.01); C07D 413/12 (2006.01); C07D 213/18 (2006.01);
U.S. Cl.
CPC ...
A61K 31/422 (2013.01); A61K 31/497 (2013.01); C07D 213/18 (2013.01); C07D 241/12 (2013.01); C07D 263/12 (2013.01); C07D 413/12 (2013.01);
Abstract

The invention provides oxazolidine and thiazolidine derivatives that are useful as subtype selective alpha 2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with selective subtype modulation of alpha 2 adrenergic receptors.


Find Patent Forward Citations

Loading…